Oct 14, 2025 17:46
IMA - ImageneBio, Inc. Common Stock
| Day | 1m | 10m | 60m | PreMarket | Market | AfterHours | Gap |
|---|---|---|---|---|---|---|---|
| 7.56 0.02 (0.26%) | --- | --- | --- | 0.0 (0.0%) | -0.04 (-0.59%) | --- | 0.0 (0.0%) |
ImageneBio Inc is a clinical-stage biopharmaceutical company that develops differentiated therapies for immunological and inflammatory (I&I) diseases. The company is focused on developing IMG-007, a non-depleting anti-OX40 monoclonal antibody, for the treatment of atopic dermatitis.
Market Period:
Closed
Earnings & Ratios
- Basic EPS:
- -0.1
- Diluted EPS:
- -0.1
- Basic P/E:
- -75.8
- Diluted P/E:
- -75.8
- RSI(14) 1m:
- 100.0
- VWAP:
- 7.6
- RVol:
- 0.1562
Events
| Period | Kind | Movement | Occurred At |
|---|